Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement-Reference-Cited by-同舟云学术

Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement

Published:2020-10-06 Issue:12 Volume:11 Page:2791-2827
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Roy Ajitesh,Maiti Animesh,Sinha Anirban,Baidya Arjun,Basu Asish Kumar,Sarkar Dasarathi,Sanyal Debmalya,Biswas Dibakar,Maisnam Indira,Pandit Kaushik,Raychaudhuri Moutusi,Sengupta Nilanjan,Chakraborty Partha Pratim,Mukhopadhyay Pradip,Raychaudhuri Pradip,Sahana Pranab Kumar,Chatterjee Purushottam,Bhattacharjee Rana,Dasgupta Ranen,Saraogi Ravi Kant,Pal Salil Kumar,Mukhopadhyay Sarmishtha,Mukhopadhyay Satinath,Goswami Soumik,Chowdhury Subhankar,Ghosh Sujoy,

Funder

AstraZeneca Pharma India Ltd

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-020-00921-y.pdf

Reference115 articles.

1. International Diabetes Federation. IDF diabetes atlas, ninth ed. Brussels: Belgium International Diabetes Federation; 2019. https://diabetesatlas.org/en/resources/. Accessed 23 Dec 2019.

2. International Diabetes Federation. Diabetes facts & figureshttps://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Accessed 23 Dec 2019.

3. Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic microvascular disease: an endocrine society scientific statement. J Clin Endocrinol Metab. 2017;102:4343–410.

4. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98.

5. Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24:302–8.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and risk factors of poor glycemic control and diabetic nephropathy among patients with type 2 diabetes mellitus in Dhamar, Yemen;International Journal of Diabetes in Developing Countries;2024-05-29

2. The use of the term Black, Asian and Minority Ethnic in The Voice and Eastern Eye newspapers, a discourse analysis of Covid news stories in the UK press;Journalism;2024-05-16

3. Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks;Archives of Pharmacy and Pharmaceutical Sciences;2024-05-02

4. Association of systemic immune-inflammation index with diabetic kidney disease in patients with type 2 diabetes: a cross-sectional study in Chinese population;Frontiers in Endocrinology;2024-01-04

5. Assessment of effects of combination of SGLT2 inhibitors and renin–angiotensin–aldosterone system blockers on the renal functions of patients of diabetic kidney disease (SGRASS-DKD study);Journal of Diabetology;2024-01